3.0.0 3223 2022-11-01T07:02:34Z 2022-11-01T07:02:34Z House HR 2019-06-12 116 [Congressional Record Volume 165, Number 98 (Wednesday, June 12, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. MARSHALL:H.R. 3223.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8.[Page H4628]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-06-13T18:03:17Z Referred to 2019-06-12T14:02:40Z 2019-06-13 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-06-12 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-06-12 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-06-12 Introduced in House IntroReferral 1000 9 Library of Congress M001198 Rep. Marshall, Roger [R-KS-1] Roger Marshall R KS 1 N W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT 0 2019-06-12 True C001103 Rep. Carter, Earl L. "Buddy" [R-GA-1] Earl Carter R GA L. "Buddy" 1 2019-06-12 True G000581 Rep. Gonzalez, Vicente [D-TX-15] Vicente Gonzalez D TX 15 2019-06-12 True A000378 Rep. Axne, Cynthia [D-IA-3] Cynthia Axne D IA 3 2019-10-04 False Health Competition and antitrust Congressional oversight Consumer affairs Drug therapy Government studies and investigations Health care costs and insurance Health care coverage and access Inflation and prices Prescription drugs User charges and fees Health 00 2019-06-12 Introduced in House 2020-01-25T18:49:23Z Pharmacy Benefit Manager Accountability Study Act of 2019

This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.

]]> Pharmacy Benefit Manager Accountability Study Act of 2019 Display Title Pharmacy Benefit Manager Accountability Study Act of 2019 Official Title as Introduced To require the Comptroller General of the United States to study the role pharmacy benefit managers play in the pharmaceutical supply chain and to provide Congress with appropriate policy recommendations, and for other purposes. Introduced in House IH Short Title(s) as Introduced Pharmacy Benefit Manager Accountability Study Act of 2019 Introduced in House IH Introduced in House 2019-06-12T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr3223ih/xml/BILLS-116hr3223ih.xml 2019-06-13 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.